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AIMS: The primary objective of this study was to identify if symptom presentation 
expressed over the course of an influenza-like illness (ILI) can predict virus type by use 
of unsupervised machine learning.  The secondary objective was to describe clinical 
characteristics of strain specific coronavirus.  Finally, examine the psychometric 
properties of the Canadian Acute Respiratory Illness and Flu Scale (CARIFS).   
BACKGROUND: ILI outbreaks have been a significant source of non-battle injury 
among military personnel.  Many different viruses cause ILI, and it is difficult to 
determine which virus is causing the illness.  Recent studies have examined the etiology 
and epidemiology of ILIs.  Other studies have examined influenza virus symptom 
severity either a dichotomous or liner-sum analysis.  No studies to the researcher’s 
knowledge have examined ILI symptoms through an unsupervised learning analysis, and 
few studies have examined self-reported outpatient ILI reported symptoms over an 
extended time frame. 
METHODS: This is a secondary analysis of data collected over a four year period by the 
Acute Respiratory Infection Consortium (ARIC), from an otherwise healthy military 
population.  The symptom data was captured on visit days and by a symptom diary 
patients filled out at home using a symptom severity instrument designed for this study.  
FINDINGS: Clustering by unsupervised machine learning was unable to predict virus 
type based on physical symptom presentation over the course of ILI.  It did identify 
patient attributes, like sex and age that caused patients to experience symptoms 
differently.  Additionally, clinical similarities and differences were noted between the 
four common human coronavirus strains.  The strain HKU1 tended to have higher 
 
 
systemic symptom scores and higher gastrointestinal symptom severity score over the 
course of illness when compared to the other strains.  Finally, the psychometric properties 
of CARIFS revealed many strengths and limitations for its use in research.  The CARIFS 
should be reexamined using current knowledge of symptom management to increase the 
validity of the instrument.         
IMPLICATIONS: The results demonstrated how individuals experience physical 
symptoms differently making it difficult to predict the viral strain causing ILI.  Future 
research should focus on the development of symptom instruments using the theoretical 
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Through history, influenza virus subtypes have been responsible for pandemics 
across the world (United States Department of Health and Human Services, n.d.; Rogers, 
2010; Simonsen et al., 2013).  In 2009, a military humanitarian mission was cancelled 
due to an influenza outbreak on the main ship (BBC News, 2009).  Many viruses cause 
influenza-like illnesses such as, influenza A and B, coronavirus, rhinovirus, adenovirus, 
and they tend to be highly contagious.  The symptom presentation of the viruses can vary 
with the illness, but they also have many common overlapping symptoms.  For instance, 
respiratory syncytial virus (RSV) tends to cause more severe lower respiratory systems, 
while rhinovirus has a greater effect on the upper respiratory system; but, they share 
some common symptoms such as cough (Walsh & Hall, 2010; Turner, 2010).  The 
presentation ILI symptoms varies based on virus; therefore, it is possible to predict the 
type of virus affecting an individual.     
Background and Significance 
Theoretical Framework 
The Symptom Management Theory (SMT) is the theoretical framework that 
guided this study.  The concept of SMT was initially introduced as the Symptom 
Management Conceptual Model in 1994 by Larson and colleagues.  This model focused 
on identifying the underlying cause of a symptom and managing the total symptom 




revised in 2001 by Dodd and colleagues as more of a dynamic process where symptoms 
experienced and changes in strategy needed to occur over time.  In 2008 the framework 
was renamed Symptom Management Theory, and was introduced as a middle range 
theory by Humphreys and colleagues.  An underlying principle in the development of 
SMT is the nurses’ involvement.  Larson and colleagues stressed the importance for 
nurses to take the lead in developing a symptom model because they are more involved in 
the management of patient symptoms.  The Symptom Management Theory has a 
bidirectional conceptual relationship among symptom experience, symptom management, 
and symptom outcomes (Landers, 2014).      
Approximately twenty years ago symptom research was focused on a single 
symptom, such as pain, or known associated symptoms as stomach pain and diarrhea.  
With the development of the Symptom Management Conceptual Model leading to the 
SMT, symptoms are now looked at as a multidimensional process relying on not only one 
symptom experienced, but taking into account other factors, such as environment, health 
and illness, and different types of symptom outcomes (Dodd et al, 2001).  Dodd and 
colleagues (2001) defined symptoms as subjective experiences echoing individual 
changes in sensations and biopsychosocial and cognitive functioning.  Many recent 
studies have utilized SMT to guide their symptom research in the fields of HIV, cancer, 
and constipation focusing on symptom experience with self-care outcomes.  A study by 
Dodd, Cho, Cooper, and Miaskowski (2010) was supported by the concepts of SMT, and 
reported symptoms are experienced in clusters.  The study examined specific symptom 




time points over the course of treatment.  Lenz, Rugh, Milligna, Gift, & Suppe (1997) 
indicated symptoms have a reciprocal link between physiologic, psychologic, and 
situational factors, and multiple symptoms are multiplicative, not additive. 
Symptom Management Theory is divided into three key components: symptom 
experience, symptom management strategies, and patient outcomes (see figure 1).  All 
three components of SMT are within the three domains of nursing science: person, 
environment, and health and illness.  For the purpose of this research study, the SMT 
component of interest was symptom experience, specifically perception and evaluation of 
symptoms.  Symptom experience is defined as the intensity, misery, and occurrence of 
symptoms as they are produced (Armstrong, 2003).  According to SMT, symptom 
experience is evaluated within the three domains of nursing science (Humphreys et al, 
2014).  With the strict inclusion/exclusion criteria of the data collected for the research 
study, the researcher made the assumption that the three domains of nursing science were 




FIGURE 1- Theoretical framework for study: Symptom Management Theory 
From “Nursing theory and concept development or analysis: Advancing the science of 
symptom management,” by Dodd, M.J., Janson, S., Facione, N., Faucett, J., Froelicher, 
E.S., Humphreys, J…, Taylor, D., 2001, Journal of Advanced Nursing, 33(5), 668-676. 






Currently, based on symptomatology, there are a multitude of different definitions 
as to what classifies an illness as influenza or influenza-like.  The World Health 
Organization (WHO) defines influenza-like illness as an acute respiratory infection with 
onset in the last 10 days with cough and measured fever, but they do not provide a clear 
definition on the diagnosis of influenza (World Health Organization, 2014).   The 




diagnosis of influenza can be made if six of the nine influenza-like symptoms occur: 
sudden onset, cough, chills, fever, weakness, headache, myalgia, no physical signs other 
than redness of nasal mucous and throat, and influenza close contacts (Govaert, Dinant, 
Aretz & Knottnerus, 1998).  The Center of Disease Control and Prevention (CDC) 
defines influenza-like illness as a fever, cough and/or sore throat with the presence of a 
sick contact or potential epidemic, and leaves the diagnosis of influenza vague, based on 
symptoms alone (Center for Disease Control and Prevention, 2015).   
In the literature, a variety of diagnostic criteria exists to classify an illness as 
influenza-like.  Common themes to the diagnosis of influenza-like illness include fever, 
sudden onset, cough, and potential for other symptoms typically related to influenza.  For 
the purpose of this study, influenza-like illness is defined as: a fever over 100.4 ℉ and 
respiratory symptoms (cough, sputum production, shortness of breath, chest pain) and/or 
sore throat. 
Viruses associated with ILI 
There are over 200 different viruses that produce influenza-like symptoms 
(Eccles, 2005).  A recent systematic review of studies examining the concept of 
influenza-like illness identified people who presented with ILI symptoms, and the 
common viruses experienced were: adenovirus, coronavirus, influenza A/B, human 
metapneumovirus, parainfluenza, picorna virus, respiratory syncytial virus (RSV), and 
rhinovirus (Thomas, 2014).   Research continues to grow in the area of being able to 
distinguish viruses based on patient symptomatology (Puzelli et al., 2009).  The 




data collected, location, and age group.  The most common viruses to cause ILI 
symptoms are: adenovirus, rhinovirus, influenza A/B, coronavirus, RSV, and human 
metapneumovirus (Puzelli et al., 2009; Thomas, 2014).  
Adenoviruses are common with over 100 identified across all species with the 
infection being self-limiting.  Adenoviruses are known to cause respiratory tract 
infection, ocular disease, and gastrointestinal tract disease (Rhee & Barouch, 2010).  
Rhinoviruses account for approximately 40% of all cases of upper respiratory infection.  
Rhinovirus infections are typically classified as the ‘common cold,’ causing symptoms 
mostly concentrated in the upper respiratory tract (Turner, 2010).   
The influenza virus is divided into types, A and B.  Influenza type A is known to 
cause global pandemics with high mortality in the younger population, while influenza B 
typically does not result in pandemics and occurs in older adults or high-risk population.  
Clinical manifestations of influenza are: fever, sore throat, cough, and malaise, and there 
is a vaccine developed yearly to help prevent the illness (Treanor, 2010).   
Respiratory syncytial virus (RSV) infections tend to attack the lower respiratory 
system, and is the most frequent cause of bronchiolitis in infancy and influenza-like 
symptoms in the adult population.  The clinical manifestations of RSV differ by the age 
group infected with young children experiencing bronchiolitis, pneumonia, and some 
upper respiratory tract symptoms, while older children and adults present mostly lower 
respiratory tract symptoms and pneumonia (Walsh & Hall, 2010).  Human 
metapneumovirus (hMPV) is a newly discovered virus, first described in 2001, and 




clinical manifestations are similar to RSV and pneumonia with the most common 
symptoms associated with it being fever, nasal congestion, and cough (Falsey, 2010).     
Coronaviruses are known to cause upper respiratory symptoms in humans, and 
cause 15%-35% of the influenza-like illnesses reported in clinics (McIntosh & Perlman, 
2010).  The severe acute respiratory syndrome (SARS) and Middle East respiratory 
syndrome (MERS) viruses have been the focus of many coronavirus studies, while the 
common human sub-types have not.  The four common types of coronavirus are known 
to cause upper respiratory symptoms similar to influenza, but few studies have examined 
the characteristics of the different strains (McIntosh & Perlman, 2010). 
ILI Symptoms 
When people experience influenza-like illness symptoms, it is common for them 
to diagnose themselves with a ‘cold’ or the ‘flu’ (Eccles, 2005).  ILI symptom experience 
varies, but the most common reported symptoms include: fever, cough, rhinorrhea, and 
sore throat.  Because symptom experience is subjective, it is difficult to determine which 
virus is the cause of ILI without laboratory testing.  
The progression of symptom experience differs from person to person, but most 
literature agrees ILI typically starts with a fever and progresses to upper respiratory tract 
symptoms (Eccles, 2005; Tyrrell, Cohen, & Schlarb, 1993).  There are some ILI viruses 
that cause systemic and gastrointestinal symptoms in addition to the respiratory tract 
symptoms. Although people with ILI characterize the symptom experience as the worst 
part of the illness, these symptoms may actually help them overcome the illness with the 




Symptom severity experience is subjective, and can build off previous illness 
knowledge.  Due to the variety of symptoms people experience with influenza-like 
illnesses, it is difficult to advise people when to seek treatment with symptoms because 
they may be conflated with other ailments.  People have reported not taking the diagnosis 
influenza seriously, and continued their daily life activities, while other strongly 
recommended seeing a healthcare provider as soon as possible and were worried about 
being a vector for the virus (Jutel & Banister, 2013). 
ILI Symptom Measurement 
The scale used for capturing symptom severity of ILI for this project came from 
the Acute Respiratory Infection Consortium (ARIC).  ARIC used the scale in their 
longitudinal influenza-like illness research, specifically in the military population (Chen 
et al, 2015).   During the development of ARIC’s protocol, the researchers could only 
identify one validated ILI symptom severity tool, the Canadian Acute Respiratory Illness 
and Flu Scale, but it was specifically designed for children (Jacobs et al, 2000).  
Therefore, ARIC developed their own symptom severity scale utilizing aspects from four 
similar non-validated symptom severity scales they termed: Hayden I, Hayden II, Keech, 
and ICCSQ (Devoulyte & Sullivan, 2003; Hayden, Fritz, Lobo, Alvord, Strober, & 
Straus, 1998; Keech, Scott, & Ryan, 1998; Treanor et al., 2000).   
The scale created by ARIC has 20 symptoms which people with ILI rank on a 
four point scale, and are broken down into four subscales: systemic, upper respiratory, 
lower respiratory, and gastrointestinal.  The 20 question symptom scale is written in 




accurately.  The four point symptom severity scale is similar to the Hayden I and II scale 
where 0=none, 1=mild, 2=moderate, and 3= severe.  Recently the ARIC group has 
developed and validated a new ILI symptom measurement instrument, Flu-PRO, utilizing 
the symptom data from this project (Powers et al., 2013; Powers et al, 2016).   
ILI and the Military 
A person’s age, physical state, and current immunological status can have an 
effect on ILI symptoms experienced.  Many studies focus on ILI symptomatology in the 
older adult or young child population, as they are considered the most vulnerable.  
However, historically military members have been vulnerable to influenza outbreaks with 
ILI being the leading cause of outpatient reported illness in the military (Gray, Callahan, 
Hawksworth, Fisher, & Gaydos, 1999).       
The United States military population is unique since they are generally young, 
healthy individuals.  Active duty military members must have constant readiness to 
protect and serve the United States, and must be continuously aware of their health and 
fitness state; but, they are a high-risk group for ILI due to their occupation and other 
factors, such as living arrangements. 
Some members of the United States military live in barracks or in close-living 
conditions, which can increase the transmit ability of a virus.  Some may also live with 
their family who work with the outside community where a virus outbreak could be 
occurring.  Additionally, active duty military members tend to have an increase in 
psychological stress and difficulty maintaining personnel hygiene depending on where 




Other Factors influencing ILI symptoms 
Immunologically, the response to a viral infection differs based on a person’s 
gender due to genetic and hormonal differences.  The WHO examined the effects of an 
influenza virus infection on gender globally, and noted a difference in symptom 
experience and mortality rates in some regions of the world (World Health Organization, 
2010).  In the Netherlands a study compared day to day symptom experience in males to 
females.  Overall females had higher summed symptom scores and greater symptom 
reporting when compared to the males (Gijsbers van Wijk, Huisman, & Kolk, 1999).       
People who smoke or are former smokers are known to have a decrease in their 
lung function due to the components of cigarette smoke, including carcinogens.  During 
an outbreak of influenza A in 1979, an Israeli military unit was studied to identify the 
effects of smoking on disease severity and susceptibility on female recruits.  The data 
showed women recruits who smoked reported more severe influenza-like illness and high 
rates of contraction of illness (Kark & Lebiush, 1981).  Another study examined the 
effects of smoking on U.S. Army recruits in 1982 with results showing those who 
smoked were more likely to be seen for an upper respiratory tract infection (Blake, Abell, 
& Stanlet, 1988).    
Body mass index (BMI) is a measure of body fat based on a person’s weight and 
height for the adult population.  Many obesity-related factors have potential to affect the 
outcome of infectious diseases such as, obstructive sleep apnea, decreased pulmonary 
volumes, decreased wound healing, and dysregulated immune responses in the lung 




illness severity during the 2009 influenza A pandemic (Louie et al., 2011; Yu et al., 
2011).   
Studies have shown a person’s ethnicity can influence symptom presentation in 
many diseases, including viral illnesses (Corley, D.A., Kubo, A., & Zhao, W., 2007; 
Pattermore, Asher, Harrison, Mitchell, Rea, & Stewart, 1989; O’Connor et al, 2003).  
CDC reports indicated self-reported ILI were lower in Hispanics and non-Hispanic blacks 
and higher in American Indians during the 2009 influenza pandemic.  Additionally, 
minorities had higher rates of hospitalizations when compared to non-Hispanic whites 
(Dee et al, 2011).  A pediatric population-based surveillance study of several ILI viruses 
noted patients who were Hispanic and non-Hispanic black had higher rates of 
hospitalizations (Iwane et al, 2004).       
Statement of the Problem 
The review of literature identifies the need for further understanding of ILI 
symptom experience, especially in the young adult/ military population.  Studies 
predicting virus types based on patient reported ILI symptoms limited.  Most of the 
studies predicting virus type focus on the patient having or not having influenza without 
consideration of the other viral types.  Additionally, there is a gap in knowledge 
regarding symptom experience in the military population, which is unique compared to 
the general population.     
Another gap in knowledge identified was classifying the symptom experience in 
people experiencing the more common forms of human coronavirus.  A majority of the 




examining the common forms of coronavirus may lead to better understanding of future 
mutated forms of the virus. 
Purpose of the Study 
The purpose of the study is to explore and characterize ILI and symptom 
experience in a military population, and determine if symptom presentation can predict 
virus type.  This study is a secondary analysis of data collected from an observational, 
longitudinal military cohort study designed to determine the etiology, epidemiology, and 
clinical characteristics of ILI.  Secondary data analysis studies are useful because they 
allow researchers to examine data in other ways than originally intended with bigger 
numbers for analysis, but can also be limiting because further data collection from 
participants involved is difficult to complete.  This design method is appropriate for the 
purpose of this study because the use of already collected data will provide more 
variables for analysis and larger numbers for a more thorough analysis.   
Specific Aims of the Three Papers 
This dissertation consists of three manuscripts written for publication in various 
journals.  The manuscripts are formatted per the guidelines of the journal for potential 
publication.  The specific aims for each paper are: 
1. Identify if symptom presentation over the course of influenza-like illness (ILI) 
can predict virus type in an otherwise healthy military population using 
unsupervised machine learning; Identify sub-populations with similar 




2. Describe the strain specific clinical characteristics of coronavirus among an 
otherwise healthy US military population. 
3. Examine the psychometric properties of one of the few validated instruments 
examining disease severity of ILI, the Canadian Acute Respiratory Illness and 
Flu Scale (CARIFS).  
Summary 
During the 2014-2015 influenza season, the CDC’s outpatient illness surveillance 
reported ILI activity being at or above the baseline measure for 20 weeks, which made it 
the longest season for reported ILI activity (Center for Disease Control and Prevention, 
2015).  Symptom experience is a subjective measure, which makes it difficult to identify 
the type of virus that may be causing the symptoms.  Utilizing the military database to 
analyze ILI symptoms that active duty and their beneficiaries experience will provide the 
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Of over 350,000 samples were collected from the 2012-2013 flu season, only 21% were 
positive for an influenza virus.  ILI outbreaks are a significant source of non-battle injury 
among military personnel and may lead to mission cancellations. Prior studies of 
influenza symptom severity used dichotomous or linear sum analysis but few examined 
symptoms over the course of the illness. No studies to the researcher’s knowledge have 
examined ILI symptoms through an unsupervised machine learning analysis. 
Aims 
The primary objective is to identify if symptom presentation over the course of influenza-
like illness (ILI) can predict virus type in an otherwise healthy population using 
unsupervised machine learning.  The secondary aim is to identify sub-populations with 
similar symptom experience.  
Methods 
The Acute Respiratory Infection Consortium (ARIC) conducted a prospective 
longitudinal study from 2009-2014 to determine the etiology, epidemiology, and clinical 
characteristics of ILI.  The sample population (n=1590) was healthy active duty military 
members, healthy retirees, and their dependents from five US treatment 
facilities.  Subjects recorded symptoms on days 0, 3, and 7 using a tool designed for this 
study. Nasopharyngeal samples were collected for virus identification. This analysis only 




Unsupervised machine learning algorithm k-means clustering analyzed the data in two 
ways.  In both approaches, patients were clustered by the individual symptom score for 
every visit to capture severity and illness progression.  In the first analysis, patients of all 
virus types were clustered with patients without a viral diagnosis.  The other analyses 
clustered patients diagnosed with the most prominent viruses (influenza A, rhinovirus, 
and coronavirus) separately. 
Results 
The primary analysis was unable to predict virus type or differentiate those with and 
without a virus based on patient symptom experience using a variety of scoring 
approaches. The secondary analyses with rhinovirus (n=101), influenza A (n=107), and 
coronavirus (n=51) each yielded at least one symptom cluster with a statistically 
significant difference based on non-symptom features using one-way ANOVA or chi 
square testing.  The clustered rhinovirus data showed the most statistically significant 
differences amongst the clusters in the attributes: sex, BMI, age, smoking history, and 
military status.  The clustered influenza A data showed a statistically significant 
difference in clusters based on sex and ethnicity.  The clustered coronavirus data only 
showed some differences amongst clusters in regards to sex, which was expected as the 
data set was well distributed.  Overall the patients in the different virus clusters 






The most common cause of illness and visits to healthcare providers in the United 
States (US) are influenza-like illnesses (ILI).  The annual cost associated with ILI in the 
US is estimated to be over 12 billion dollars.  An ILI is defined as having an acute 
respiratory infection with fever and presence of sick contact, and is typically caused by a 
contagious virus (Center for Disease Control and Prevention, 2015; World Health 
Organization, 2014).   The Center of Disease Control and Prevention (CDC) established a 
surveillance network called, U.S. Outpatient Influenza-like Illness Surveillance Network 
(ILInet), which continuously monitors ILI in the outpatient setting.  The network allows 
information about the rate of ILI infections across the US be monitored (Center for 
Disease Control and Prevention, 2015).    
Historically, there have been several ILIs that reached pandemic levels with the 
most notable being the Spanish Flu of 1918, which affected the global population, but in 
the US the hardest hit population was the military (Gray, Callahan, Hawksworth, Fisher, 
& Gaydos, 1999).  During World War I, the US military suffered more deaths from the 
influenza outbreak of 1918-1919 than combat casualties.  The poor environmental 
conditions the service members endured, combined with a delay in enacting quarantine 
procedures, led to the high number of infections and morbidity (Byerly, 2010).      
Military 
Almost one hundred years later, ILI outbreaks still affect military readiness. In 
2009 the United States Department of the Navy had to cancel a planned humanitarian 




News, 2009).  Although the active duty military population are known to be healthy, 
young and active; they are still at higher risk for ILI due to their housing and working 
environment (Gray, Callahan, Hawksworth, Fisher, & Gaydos, 1999).         
Many enlisted members continue to live in close quarters such as barracks.  Some 
live off base with their family, but others live in close knit military communities.  Most 
members share common areas daily, such as the mess hall, gym, or even stair wells.  
Additionally, depending on a service members’ duty station, they may experience an 
increase in psychological stress and/or difficulty maintaining personal hygiene, therefore, 
decreasing their ability to fight off an infection (Gray et al., 1999; Kocik et al. 2014; 
Padin et al., 2014).  All these situations put the current active duty members at an 
increased risk for an ILI outbreak. 
ILI is the leading cause of outpatient reported illnesses in the military (Gray, 
Callahan, Hawksworth, Fisher, & Gaydos, 1999).  Most ILI research studies focus on 
population extremes, such as young children or older adults, or those people with 
underlying conditions.  Most members of the US military do not meet these descriptions, 
so it is important to understand how ILIs affect this population due to them having to be 
constantly ready to deploy. 
Symptom Experience   
  Symptoms are subjective experiences stimulating changes in a person’s feelings 
and biopsychosocial factors; therefore, people’s experience of symptom severity may 
vary (Dodd et al, 2001).  Several studies have examined the symptom experience of 




satisfactory results (Peltola, Reunanen, Ziegler, Silveinnonen, & Heikkinen, 2005; Puzelli 
et al, 2009). The symptoms of cough and fever during the influenza season were found to 
be better predictors of influenza, but study limitations are the lack of a uniform method of 
symptom measurement.     
Biological, psychological, and social factors can contribute to a person’s symptom 
experience.  Studies have shown a person’s history of smoking can have an effect on ILI 
susceptibility and severity most likely stemming from the structural changes in the lungs 
caused by the smoke inhalation (Arcavi & Benowitz, 2004; Blake, Abell, & Stanlet, 
1988; Kark & Lebiush, 1981).  A person’s body mass index (BMI) is a risk factor for 
worse illness severity as demonstrated recently with the H1N1 outbreak; people with 
higher BMIs tended to have worse symptom severity (Louie et al., 2011; Yu et al., 2011).  
Additionally, a Canadian study noted, a positive association between increased BMI and 
rates of respiratory hospitalizations during the influenza season (Kwong, Campietelli, & 
Rosella, 2011).   
 Gender can also influence the response of a viral infection due to genetic and 
hormonal differences.  There is a gender difference between symptom severity and 
influenza infection outcome with females having higher morbidly and mortality rates 
(World Health Organization, 2010).  Gijsbers van Wijk, Huisman, & Kolk (1999) studied 
daily symptom experience in males and females, and noted females had a higher summed 
symptom scores.  A person’s ethnicity can also influence symptom presentation.  During 
the 2009 H1N1 pandemic, the CDC noted self-reported ILI was lower in Hispanics and 




for minorities when compared to non-Hispanic whites (Dee et al, 2011).  A pediatric 
population-based surveillance study of several ILI viruses noted patients who were 
Hispanic and non-Hispanic black had higher rates of hospitalizations (Iwane et al,2004).       
Unsupervised Machine Learning 
Unsupervised machine learning is a process that detects patterns in data with 
minimal human guidance.  One of the most common approaches to unsupervised learning 
is called clustering, wherein samples are grouped together based on similarity.  The 
resulting clusters can be used for classification, population segmentation, or be further 
analyzed for common features.  This paper employs a technique called k-means 
clustering, which is described below. 
K-means clustering (MacQueen, 1967) is one of the simplest, but also one of the 
most widely-used and easily understood forms of unsupervised learning.  While there are 
numerous extensions and improvements to the algorithm, the most basic approach starts 
by randomly selecting k points to serve as representative points of each cluster.  Then, all 
samples in the data set are assigned to one of these points, based on similarity.  Next all k 
representative points are moved to the mean of all the sample points that were assigned to 
them.  This process of assigning points to clusters and updating the means of those 
clusters is repeated until the points assigned to a mean are unchanged, i.e. the algorithm 
has convergence, or a fixed number of reassignments occurs.  The value of k in k-means 
clustering must be provided by the experimenter and is typically based on domain 






This clustering algorithm has been applied to many problem domains such as 
image segmentation (Ng et al, 2006), feature learning (Coates, 2012), and user 
classification (Lingras, 2004).  Some notable medical applications of k-means clustering 
include predicting the recurrence of breast cancer (Belciug et al, 2010) and detection of 
Alzheimer’s disease (Escudero et al, 2011).   
Studies examining patient reported ILI symptoms to predict virus type are limited, 
especially related to virus types other than influenza.  Most research focuses on the 




influenza virus and symptoms, and not the other common viruses identified as sources of 
ILI.  The military population is a unique population when compared to the general 
population, and there is limited knowledge regarding symptom experience in the military.  
Additionally, there are no studies to the authors’ knowledge that utilize unsupervised 
machine learning to identify if symptom severity can predict ILI virus type.  
Objectives 
The primary objective is to identify if symptom presentation over the course of 
influenza-like illness (ILI) can predict virus type in an otherwise healthy military 
population using unsupervised machine learning.  The secondary aim is to identify 
subpopulations with similar symptom experience.  
Methods 
Study Design 
A secondary analysis of symptom severity data from a prospective ILI study 
conducted by the Acute Respiratory Infection Consortium (ARIC) whose methods for 
data collection have previously been reported (Chen et al, 2015).  This study received 
exempt status approval from the University of San Diego.  Below is a summary of the 
methods ARIC utilized for its prospective study. 
Overview of ARIC study 
The ARIC conducted a longitudinal study for the purpose of determining the 
etiology, epidemiology, and clinical characteristics of ILI among healthy active and 
retired military personnel and their beneficiaries.  The study data was collected from 




was approved by the Infectious Disease Institutional Review Board of the Uniformed 
Services University of Health Sciences (IDCRP-045), and written informed consent was 
obtained prior to data collection. 
 Population 
Patients aged 0-65 years who presented to the clinic within 72 hours of influenza-
like illness (ILI) symptoms were included into the study.  ARIC defined ILI symptoms as 
having a self-reported fever above 100.4F with at least one of the following upper 
respiratory symptoms: cough, shortness of breath, chest pain, sputum production, sore 
throat).  Patients with a history of chronic disease such as, COPD, uncontrolled asthma, 
diabetes, immunodeficiency, heart disease, neuromuscular disease, or renal disease were 
excluded from the study.  
Demographic and patient history data were captured at enrollment.  
Nasopharyngeal samples were collected for virus identification analysis. Symptom data 
was captured prospectively on visit days 0, 3, 7, 28, and by a take-home seven-day 
symptom diary.      
Symptom severity and virus identification tools 
Clinical symptom severity was captured by a symptom severity instrument 
created for this study.   The instrument was modified from several ILI symptom severity 
instruments, and included rating 20 symptoms.  The patients were instructed to rate their 
severity on an ordinal scale with 0=none and 3= severe on daily basis in their seven day 
symptom journal and at all scheduled study visits.  The symptoms on the instrument 




difficulty, dizziness, hoarseness, chest pain, muscle ache, sneezing, joint pain, fatigue, 
headache, chills, abdominal pain, nausea, vomiting, and diarrhea.   
The nasopharyngeal swabs collected were analyzed by multiplex assays (xTAG 
Respiratory Viral Panel, Luminex, Austin, TX pr PLEX-ID Viral IC Spectrum, Abbott, 
Chicago, IL). The multiplex assays detected the presence of the following viral 
respiratory pathogens: influenza A and B, adenovirus, rhinovirus, coronavirus, 
respiratory syncytial virus, parainfluenza virus, bocavirus, coxsackievirus/echovirus, and 
metapneumovirus.  
 Sample used in current study 
Participants aged 0-65 with complete symptom severity measurements for visits 
0, 3, and 7 were included in analysis.  Any cases with incomplete symptom severity 
measures and/or a co-detection of another respiratory virus were excluded from analysis.  
People with bacterial co-infections were not excluded because the study focused on viral 
illnesses.  Only the symptom visit data, demographic information, and viral diagnosis 
were needed for the analyses.         
Data Analysis 
Descriptive statistics were used to create and analyze the dataset for this study.  
Basic demographic information such as, age, sex, geographic location, ethnicity, military 
rank, and BMI were analyzed to determine distribution of data.    
Primary Objective 
All eligible patients were clustered together according to symptom expression on 




for a total score or system scores.  The distribution of viral diagnosis for each cluster was 
then compared to the distribution of the entire population to determine if any of the 
resulting clusters represented a specific virus type or group of virus types.  Groups that 
were different were further analyzed to determine what unique symptom expressions 
caused them to cluster together and could potentially be associated with one or more 
viruses.  Because it was unclear if different viruses may express similarly (and therefore 
cluster together) clustering was run with k values ranging from 5 to 10 clusters. 
Secondary Objective 
Patients were grouped together based on viral diagnosis to correct for symptoms 
that may be specific to a particular virus type. Only three viruses, influenza A, 
coronavirus, and rhinovirus, had sufficient numbers to perform meaningful clusters.  The 
patients in each group were clustered on symptom expression, and compared based on 
demographic information (sex, military status, age, BMI, smoking, ethnicity) to 
determine if any clusters represented how a specific group may experience an 
illness.  Patients with these viruses were clustered with k set to five for rhinovirus and 
influenza A and four for coronavirus due to the smaller sample set for coronavirus.   
The distribution of attributes for each cluster were then compared to the 
distribution of the entire population for that virus.  Groups with different attributes had 
Chi square test or one-way ANOVA test performed (based on variable type) to identify if 
there were any statistically significant differences between the clustered groups based on 
symptom data that caused them to cluster together.  If statistical significance was found 




All statistical analyses were performed using SPSS software, version 22 (IBM 
corporation).  Clustering was performed with scikit-learn version 0.17.1’s 
implementation of K-Means Clustering on Python 2.7.6, with default parameters except 
for the number of clusters which were varied as part of the experiments. 
Results 
Demographics 
ARIC had a total of 1590 patients with viral diagnosis data, but over 50% of those 
patients had missing symptom data for their visits.  For that reason, a subsample of 699 
was mined that included only patients who had complete symptom data for visits 0, 3, 
and 7.  The sample was amended further to exclude patients with viral co-infections to 
reduce the possibility of symptom interaction.  A total of 645 patients’ data was used for 
analysis (see fig. 2).  
 





Predicting virus type 
The goal of the first experiment was to determine if a particular ILI virus has 
universal symptom expression among all patients, allowing it to be uniquely identified by 
physical symptoms alone.  After initial analysis, only the k=7 clustering demonstrated 
promising differences (see figure 3).  Detailed analysis of this clustering revealed that all 
clusters were not significantly different than the population (p > 0.05 for all clusters and 
virus types) except for a one cluster (cluster 3, fig. 3) had a statistically significant 
difference (p<.000) and coronavirus percentage (17.3%) when compared to the overall 
population (7.9%).  However, this cluster contained eight total virus types, some with 
similar percentages (16.4% influenza A and 14.5% rhinovirus); thus, it would not be very 
helpful in an absolute diagnosis.  An ideal cluster distribution would be heavily skewed 
towards one or two virus types.  Overall, this experiment was unable to predict virus type 
or differentiate those with and without a virus based on individual patient symptom 






The second experiment attempts to identify if different patient attributes may 
cause them to experience a virus differently.  For example, people who smoke are more 
likely to have compromised lung function; therefore may present with more severe 
respiratory symptoms when compared to a non-smoker with the same illness.   
There were a total of nine viruses in the data set, but only three had sufficient 
numbers to run the analysis: rhinovirus (n=101), influenza A (n=107), and coronavirus 
(n=51).   The patient attributes examined were: age, military status, BMI, sex, smoking 
history, and ethnicity.  Each clustering by virus type yielded at least one symptom cluster 
with a statistically significant difference based on patient attributes.   
Five out of the six attributes in the clustered rhinovirus data had statistically 





































aspects of patients within the clusters were attributing to the differences. Analyses 
showed that cluster 2, as seen in table 1, had statistically significant differences in 
military rank, more likely a dependent (p<.000), smoking status, non-smoker (p<.01), 
BMI, underweight BMI, (p<.000), and age, less than 12 (p<.000).  The underweight BMI 
was expected with this cluster due to the group being mostly patients under 12; therefore, 
it is difficult to use this attribute.  Cluster 4 demonstrated statistical significant difference 
in sex, more females (p<.000), and cluster 3 had significant statistical difference in 
smoking history (p<.000).   
Examining the median symptom scores per cluster implies a younger population 
(as seen in cluster 2) with rhinovirus do not have as severe of symptoms as adults and 
experience eye pain (see table 4); or, females (as seen in cluster 4) present with more 
severe upper respiratory symptoms (table 4).   
The clustered influenza A data showed a statistically significant difference in 
clusters based on sex and military status (see table 2).  Bonferroni post hoc analyses 
though revealed only cluster 3 had statistical significant difference in sex (p<.000), while 
cluster 4 was approaching a statistically significant difference in military status.  
Examining the median symptom scores for cluster 3 (see fig. 4), infers females have 
lingering coughs and runny noses with initial headache presentation when compared to 
the population total.   
The clustered coronavirus data only showed a statistically significant difference in 
clusters in regards to sex (table 3), but Bonferroni post hoc analysis revealed clusters 3 




scores for the clusters show cluster 4, which was all female, tended to express worse 
upper respiratory symptoms, while cluster 3 (mostly males) tended to express worse 
systemic scores when compared to the total population (see figure 4). 
Table 1: Rhinovirus attributes by cluster 
 
 Total Cluster1 Cluster2 Cluster3 Cluster4 Cluster5 pa 
 N=101 N (%) N (%) N (%) N (%) N (%)  
Age (yrs)        
0-12.9 13   0 ( 0) 12(71)   0 ( 0) 0 ( 0)   1 ( 3) .000 
13-17.9 1   0 ( 0)   1 ( 6)   0 ( 0) 0 ( 0)   0 ( 0)  
18-34.9 63 10(67)   3(18) 21(81) 5(62) 24(68)  
35-65 24   5(33)   1 ( 6) 5(19) 3(38) 10(29)  
        
Sex        
Male 65 9(60) 10(59) 19(73) 0 (   0) 27(77) .001 
Female 36 6(40)   7(41)   7(27) 8(100)   8(23)  
        
Ethnicity        
White 70 9(60) 11(65) 16(61) 7(87) 27(79) .369 
Black 13 2(13)   5(29)   2 ( 8) 1(12)   3 ( 9)  
Asian 6 1(  7)   0 ( 0)   4(15) 0 ( 0)   1 ( 3)  
Other 11 3(20)   1 ( 6)   4(15) 0 ( 0)   3 ( 9)  
        
History of Smoking       
Yes 39 8(53) 2(12) 18( 6) 1(13) 10(29) .000 
No 62 7(47) 15(88)   8(21) 7(87) 25(71)  
        
Body Mass Index       
<18.5 11 0 ( 0) 9(53) 19(73) 0 ( 0)   1 ( 3) .000 
18.5-24.99 25 3(20) 4(23)   7(27) 5(63)   6(17)  
25-29.99 39 7(47) 1 ( 6) 19(73) 2(25) 20(57)  
>30 24 5(33) 2(12)   7(27) 1(12)   7(20)  
missing 2 0 ( 0) 1 ( 6)   0 ( 0) 0 ( 0)   1 ( 3)  
        
Military Status       
Active Duty 74 11(73)   4(2%) 24(9%) 6(75) 29(83) .000 
Dependent 23   3(20) 13(77)   1 ( 4) 1(12)   5(14)  






Table 2: Influenza A attributes by cluster 
 
 Total Cluster1 Cluster2 Cluster3 Cluster4 Cluster5 pa 
 N=107 N (%) N (%) N (%) N (%) N (%)  
Age (yrs)        
0-12.9 7 1(11)   5(15) 0 ( 0)   0 ( 0)   1 ( 6) .100 
13-17.9 1 0 ( 0)   1 ( 3) 0 ( 0)   0 ( 0)   0 ( 0)  
18-34.9 66 3(33) 18(55) 9(56) 25(78) 11(65)  
35-65 33 5(56)   9(27) 7(44)   7(22)   5(29)  
        
Sex        
Male 69 3(33) 26(79)   4(25) 25(78) 11(65) .000 
Female 38 6(67)   7(21) 12(75)   7(22)   6(35)  
        
Ethnicity        
White 69 9(100) 18 ( 5) 12(75) 20(63) 10(59) .384 
Black 22 0 (  0)   6(18)   3(19)   7(22)   6(35)  
Asian 9 0 (  0)   6(18)   0 ( 0)   3 ( 9)   0 ( 0)  
Other 6 0 (  0)   2 ( 6)   1 ( 6)   2 ( 6)   1 ( 6)  
Missing 1 0 (  0)   1 ( 3)   0 ( 0)   0 ( 0)   0 ( 0)  
        
History of Smoking       
Yes 35 3(33) 10 ( 3) 4(25) 11(33) 7(41) .898 
No 72 6(67) 23(70) 12(75) 21(66) 10(59)  
        
Body Mass Index       
<18.5 11 0 ( 0)   4(12)   0 ( 0)  1 ( 3) 1 ( 6) .132 
18.5-24.99 25 2(22) 10(30)   3(19) 10(31) 7(41)  
25-29.99 39 3(34)   8(2%) 10(63)   5(16) 4(24)  
>30 24 2(22)   7(21)   2(12) 14(44) 5(29)  
missing 9 2(22)   4(1%)   1(6)    2 ( 6) 0 ( 0)  
        
Military Status       
Active Duty 74 2(22) 18(54) 10(63) 27(84) 12(71) .031 
Dependent 23 6(67) 11(33)   5(31)   4(13)   4(23)  
Retired 4 1(11)   4(12)   1 ( 6)   1 ( 3)   1 ( 6)  








Table 3: Coronavirus attributes by cluster 
 
 Total Cluster1 Cluster2 Cluster3 Cluster4 pa 
 N=51 N (%) N (%) N (%) N (%)  
Age (yrs)       
0-12.9 0   0 ( 0)   0 ( 0)   0 ( 0) 0 ( 0) .404 
13-17.9 3   0 ( 0)   0 ( 0)   3(18) 0 ( 0)  
18-34.9 41 11(85) 13(81) 13(76) 4(80)  
35-65 7   2(15)   3(19)   1 ( 6) 1(20)  
       
Sex       
Male 22 7(54)   4(25) 11(65) 0  (  0) .020 
Female 29 6(46) 12(75)   6(35) 5(100)  
       
Ethnicity       
White 30 8(61) 9(56) 9(53) 4(80) .996 
Black 11 2(15) 4(25) 4(23) 1(20)  
Asian 3 1 ( 8) 1 ( 6) 1 ( 6) 0 ( 0)  
Other 6 1  (8) 2(13) 3(18) 0 ( 0)  
Missing 1 1 ( 8) 0 ( 0) 0 ( 0) 0 ( 0)  
       
History of Smoking      
Yes 16 5(39)   6(38)   4(24) 1(20) .718 
No 35 8(61) 10(62) 13(76) 4(80)  
       
Body Mass Index      
<18.5 11  1 (8) 1 ( 6) 0 ( 0) 0 ( 0) .132 
18.5-24.99 25 5(38) 8(50) 7(41) 1(20)  
25-29.99 39 1 ( 8) 6(38) 5(29) 2(40)  
>30 24 6(46) 1( 6) 4(24) 2(40)  
Missing 9 0 ( 0) 0 ( 0) 1 ( 6) 0 ( 0)  
       
Military Status      
Active Duty 44 12(92) 13(81) 14(82) 5(100) .206 
Dependent 7   1 ( 8)   3 ( 1)   3(18) 0  ( 0)  








Table 4: Change in symptom score amongst clusters against total population 
Influenza A Rhinovirus Coronavirus 
CLUSTER 1 2 3 4 5 CLUSTER 1 2 3 4 5 CLUSTER 1 2 3 4 
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Discussion 
This is the first study to the author’s knowledge that analyzed individual symptom 
scores through unsupervised machine learning.  A majority of ILI symptom research 
focuses on determining if a patient’s symptoms can distinguish influenza from the other 
ILI viruses (Michiels, Thomas, Van Royen, & Coenen, 2011; Call, Vollenweider, 
Hornung, Simel, & McKinney, 2005; Monto, Gravenstein, Elliott, Colopy, & Schweinle, 
2000).  We attempted to differentiate all the viruses based on symptom score, but the 
technique was unable to predict virus type based on physical symptom scores.  Some 
differences in symptoms among virus types were anecdotally observed, but only one 
cluster (cluster 3, fig 3) showed statistical significance.  A larger sample size may reveal 
more statistically sound differences.   
In the literature, symptom data for viral prediction tends to be analyzed as either a 
dichotomous response or sum of scores response (Treanor et al, 2000; Monto et al, 2000; 
VanWormer, Sundaram, Meece, & Belongia, 2014).  We used the individual symptom 




analyze differences.  For instance, if only a sum of scores was analyzed, the differences 
in fever or cough may have been missed.     
The use of unsupervised machine learning provides further evidence that physical 
symptom experiences vary by person.  This concept was reinforced by the results of the 
second objective, which showed individuals experience symptoms differently based on 
individual characteristics.  For instance, the study showed that a younger population 
seems to present with less intense symptoms for rhinovirus, or women present with more 
intense upper respiratory symptoms for influenza A compared to men.  Healthcare 
providers need to take into account outside factors like environmental, biological, or 
social that are influencing symptom severity for ILI.   
Limitations 
There are several limitations to this study.  One major limitation of the analysis was 
the limited availability of patient data.  This study was a secondary analysis of previously 
collected data; therefore, data quality could not be controlled.  While the original dataset 
had over 1500 patients with viral diagnosis, over half were missing symptom reported 
visit data for the analysis period.  Additionally, another 51 patients were eliminated from 
the sample due to viral co-infections, which could have introduced bias.  A more 
controlled and larger data set would greatly improve the analysis of this data.    
Because the population used for this study was military personnel and their families, 
these results cannot be generalized to the general public as the military population is 




because the patients in that group most likely had some kind of bacterial or viral illness 
that could not identified using ARIC’s biological analysis techniques.             
Another aspect of the study that may have limited the results is how symptom 
severity was measured. The instrument used to capture symptom severity was created for 
the purpose of this study, and not psychometrically evaluated although the scale was 
derived from other published scales.  Research on symptom experience and the findings 
from this study’s second objective have shown symptoms are not just physical but may 
be affected by other sociodemographic characteristics (Armstrong, 2003; Macintyre, 
1993).  The Symptom Management Theory by Dodd et al, indicates there are three 
components to symptom presentation: symptom experience, symptom management 
strategies, and patient outcomes.  Additionally, domains outside of the individual, such as 
a person’s environment, health history, and biopsychosocial perspective, influence 
symptom perception.  Because the instrument concentrated on physical symptoms, the 
results could be biased because outside factors were unmeasured.   
Future Research 
As this was a novel approach of data analysis using a common unsupervised learning 
method, k-means clustering, further analysis with more sophisticated clustering methods 
should be performed.  With the results of the secondary analysis demonstrating the 
difference in symptom presentation by sex, age, ethnicity, future studies should look at 
outside factors that may influence symptom presentation of ILI.     
  Unsupervised machine learning could become a proven technique to help identify 




analysis and may reveal knowledge and factors that may not be obvious using traditional 
statistical approaches.  The use of it in the medical world needs to increase to further the 
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Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus in 















The increase use of diagnostic tests for influenza-like illnesses has revealed the 
symptomology of human coronaviruses can be more severe than previously understood.  
The clinical presentation between the four common human coronavirus strains varies in 






Coronaviruses (CoV) are RNA viruses that are ubiquitous in mammals, ranging 
from bats to humans.  Four human coronaviruses have been described with increasing 
frequency in humans, although human infection with animal coronaviruses does 
occasionally occur, sometimes with drastic consequences as with the SARS and MERS 
outbreaks.  Despite the publicity and high case fatality rate of those outbreaks, circulation 
of the human coronaviruses (HKU1, OC43, NL62 and 229E) is worldwide and infection 
in humans is common1-5.  As with human rhinoviruses, coronavirus were traditionally 
difficult to diagnose and were generally thought to cause uncomplicated upper respiratory 
tract infections (URI).  With the increasing use of rapid diagnostic tests for a wide range 
of respiratory pathogens, including human coronaviruses (hCoV), emerging data have 
demonstrated that human coronaviruses can cause more significant illness than initially 
thought6,7.  There are very few data on whether unique type-specific clinical syndromes 
might occur.  Using a prospective cohort study of otherwise healthy adolescents and 
adults with influenza-like illness, we sought to describe the similarities and differences in 
clinical presentation of hCoV infections. 
Methods 
The Acute Respiratory Infection Consortium (ARIC) was established in July 2009 
as a multi-site clinical research network to study ILI among otherwise healthy military 
personnel and their beneficiaries.  The aim of ARIC was to describe the natural history of 
ILI among healthy people, through an observational/ longitudinal cohort study to 




military treatment facilities across the United States.  A secondary analysis of their data 
symptom severity data from patients with diagnosed coronavirus was performed. ARIC 
methods for data collection have previously been reported15, but below is a summary of 
the methods utilized for ARIC’s prospective study. 
From 2009-2014 otherwise healthy subjects aged 0-65 who presented to one of 
the five military clinics within 72 h of ILI symptom were enrolled. ILI was defined as 
having a fever (temperature over 100.4F) with at least one of the following respiratory 
symptoms: cough, shortness of breath, sputum production, chest pain and/or sore throat. 
People with a history of diabetes (type 1 and 2), COPD, uncontrolled asthma, 
immunodeficiency, and/or chronic neuromuscular, cardiac, renal disease were excluded. 
From this cohort, we identified participants ages 13-65 who had laboratory confirmed 
coronavirus only by excluding those cases with a co-detection of another respiratory 
virus. 
Demographic information and clinical symptoms were collected by interview at 
enrollment. A nasopharyngeal specimen was collected for virus identification. 
Participants returned to clinic at days 3±1, 7±2, and 28±7 for collection of symptom data 
and additional tests.  
Additionally, clinical symptom severity was recorded by the participants utilizing 
a 7-day symptom diary, as previously described. Briefly, symptom severity was 
characterized by the sum of 4-point symptom scores in four categories: upper respiratory 
(earache, runny nose, sore throat, and sneezing), lower respiratory (cough, breathing 




chills), gastrointestinal (nausea, vomiting, and diarrhea), and total severity (the above 15 
symptoms). 
The nasopharyngeal swabs underwent multiplex testing at the Naval Health 
Research Center (San Diego, CA, USA) for detection of the following viral respiratory 
pathogens: influenza virus, adenoviruses, respiratory syncytial virus, parainfluenza virus, 
and human metapneumovirus and human CoVs. Participants aged 13-65 years old with 
corona virus types HKU1, OC43, NL63, and 229 E without co-detection of another virus 
were included in the final analysis. 
Statistical Analysis 
 Descriptive statistics were used to identify the differences in demographics, 
geographic location, and potential risk factors by corona virus type.  Severity of clinical 
symptoms were assessed by system composite score and total score for each strain type. 
Fischer exact test were utilized for categorical variables, and Kruskal-Wallis test were 
used to examine clinical symptoms for the different corona strains.  Analyses were 
performed using SPSS software, version 22 (IBM corporation). 
The study was approved by the Infectious Disease Institutional Review Board of 
the Uniformed Services University of Health Sciences (IDCRP-045) and written 
informed consent was obtained. 
Results 
Between 2009 and 2014, CoV was detected in approximately 12% of the enrolled 
ARIC participants.  Of the 111 positive participants, 29 (26.1%) were excluded because 




remaining cases were included for analysis and sub-categorized into the four different 
types of CoVs. The 82 cases had a mean age of 28 years with a range of 13 years-49 
years, and included 71 (87%) adults, 42 (51%) females, and 69 (84%) active duty 
military members.  The study population ethnicity was 60% Caucasian, 24% African-
American, 5% Asian, and 11% other.  Among the 82 cases, 23 (28%) had 229E, 18 
(22%) had NL63, 28 (34%) had OC43, and 13 (16%) had HKU1 (see figure 1).  The 
prevalence of the type of CoV did not differ by demographic characteristics, with the 
exception of the 2010-2011 flu season, which had fewer cases of diagnosed CoV 
compared to the other seasons (p=0.046). 
Figure 1: Distribution coronavirus strain by age    
Participants with HKU1 had a trend to higher visit 1 composite scores for 
gastrointestinal symptoms compared to the other virus types, but were not statistically 
significant.  The majority of participants (76%) reported persistent symptoms through day 
7.  The composite scores for upper respiratory, lower respiratory, systemic, 
gastrointestinal, and total symptoms peaked on days 3 and 4 and tended to decrease 
thereafter (figure 2).  HKU1 had statistically significant difference in composite GI 
Adults (age 21-65 years) 
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symptom score on day 4 (p=0.05), compared to the other strain types.  No other 
statistically significant symptom composite scores were noted, although higher systemic 
symptom scores for HKU1 approached significance on days 3 and 4 compared to the 






Figure 2: Symptom Severity Participant Diary 





This study was the first study to compare the epidemiology and symptom severity 
of the four common human coronavirus strains in an otherwise healthy population.  The 
longitudinal design of the study allowed for the prospective capture of self-report 
symptom severity scores utilizing a standard symptom severity instrument.  In order to 
ensure symptoms were attributable to CoVs, all cases of viral co-detection were 
excluded.  Subjects under 13 years old were eliminated because parental symptom 
reporting occurred in younger children and is difficult to compare to self-reported 
symptoms. 
 Few studies exist that describe severity differences between the CoV’s in young 
health adults, though several have been published in children5,6,8-10, or older adults with 
co-morbidities11-13.  Lau and colleagues published the results of a prospective cohort 
study of hospitalized children and adults, though the mean age was between 2 and 9 years 
of age, depending on the CoV type1. Dare et al published a similar prospective cohort of 
mixed inpatient (64, 78%) and outpatient (18, 22%) children (34, 41%) and adults (48, 
59%) and found no difference in severity between the four types3. A study of mixed 
children and adults done by Gaunt and colleagues had high rates of co-detection which 
were not removed from study data14. Our study of young healthy adolescents and adults 
with no co-detections found that coronavirus 229E was more prevalent in adolescents, 
and OC43 more so in adults.  Additionally, it was noted that the HKU1 strain had higher 
gastrointestinal symptom severity when compared to the other virus types on days 3 and 




respiratory composite scores compared to the other three virus types.  Previous literature 
has noted that HKU1 is associated with gastrointestinal symptoms than the other three 
viruses, but it has not been associated with more prolonged lower respiratory tract and 
systemic symptoms16.      
 Although the strengths of this study are the prospective data collection with 
symptoms diary validation, multiplex testing, and 5 year time-period, it is a secondary 
review of a large database not designed specifically to detail CoVs.  Additionally, the 
symptom severity diary was developed for the purpose of the original study, and was not 
a validated instrument.  Our scale is nearly identical to that used by Hayden et al for ILI 
symptom severity in neuramindase inhibitor trials, although there is no agreed upon, 
validated scale for ILI symptom severity. The small sample size (n=82) may have 
prevented us from making further associations with the coronaviruses and clinical 
outcomes, although it is one of the largest human CoV cohorts in healthy patients to-date.  
Lastly, subjects were only those who sought medical care, so it cannot be assumed that it 
represents the entire spectrum of illness from asymptomatic through severe presentations  
In summary we describe the epidemiology of symptoms in healthy adolescents 
and young adults in whom one of the four common species of coronaviruses was 
detected.  Although not often attributed to CoVs, intestinal symptoms were once again 
described, especially with HKU-1, and trends toward differential severity and duration 
were observed.    Coronaviruses should be considered as a potential cause of ILI, and 
future research on risk factors and prevention, as well as surveillance for the potential of 
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Acute respiratory illness is the most common clinical childhood illness globally, 
and there are few instruments available that measure acute respiratory illness severity, 
especially in children.  An instrument created to fulfill this gap is the Canadian Acute 
Respiratory Illness and Flu Scale (CARIFS).  The CARIFS is an instrument with reported 
psychometric testing that measures acute respiratory tract illness disease severity.  This 
article is a review of the psychometric properties of the Canadian Acute Respiratory 







Acute respiratory illness (ARI) is the most common clinical childhood illness 
globally.  In 2010, there were approximately 15 million hospital admissions globally of 
children with acute lower respiratory tract infection (Nair et al., 2013). It is estimated the 
cost associated with acute respiratory illnesses in the US is over 12 billion dollars 
annually, and yet there are a limited number of instruments available that assess and 
measure acute respiratory illness severity, especially in children (Jacobs et al., 2000).  
One of the few available instruments available is the Canadian Acute Respiratory Illness 
and Flu Scale.  
Background 
The Canadian Acute Respiratory Illness and Flu Scale (CARIFS) was originally 
developed for use in research to measure ARI disease severity among children (range 0 to 
12 years) by capturing health care professionals’ and parents’ concerns with ARI. While 
developed for research purposes, there is evidence it has been used by clinicians in 
practice (Fischer, 2014). Overall, the instrument uses a list of symptoms to measure the 
disease severity of ARI. 
Origin of Instrument 
The CARIFS was initially based upon the Kirshner and Guryatt framework for 
assessing health indices (1985). The development of the instrument began with item 
selection and face validity to reduce items as well as generate new items. Content for an 
initial 25 items was generated from the items of 13 other instruments (Hayden et al., 




Morley et al., 1991; Landgraf et al., 1996; Young et al., 1995; Msall et al., 1994; 
McCarthy et al., 1982; Pollack et al., 1996; Stein et al., 1990; Walker & Greene, 1991). 
While these instruments were used to extrapolate items, several had no published 
statistics on validity. 
Following the generation of 25 items, face validity was determined using three 
general pediatricians and 23 parents of children with ARI. As a reminder to readers, face 
validity is not a psychometric test; it is a subjective form of evaluation (Waltz, Strickland 
& Lenz, 2016). In this case, the pediatricians and parents evaluated items by ranking the 
relevance of the initial 25 items that were presented to them, each on separate cards. They 
had the option to remove cards that had items believed to be irrelevant as well as to 
generate up to five new items that they regarded as important.  That evaluation led to the 
reduction of the 25 items to 17. Only one item was added to the list (clinginess) resulting 
in an instrument with a total of 18 items.  Next, the items were subjectively grouped into 
three dimensions by the instrument authors.  The resulting dimensions included a) 
symptoms (e.g., cough, fever), b) function (e.g., not playing well, not interested), and c) 
parental impact (needing extra care, clinginess) (Jacobs et al., 2001). There are no 
published criteria available to determine what was used to group the individual items into 
these three dimensions.   
Description of Instrument  
The current version of the CARIFS contains the 18 items within the three 
dimensions described above. The instrument is to be completed by the parent of a child 




instrument.  In fact, over time, there is evidence that different researchers have used 
different timeframes for instrument completion (Shepperd, et al., 2004; Fischer et al., 
2014; Vohra et al., 2008; Whitley et al., 2001).   
Scoring 
The 18 items are scored on a four-point ordinal scale with 0= no problem, 1= 
minor problem, 2= moderate problem, 3= major problem, and not applicable= no score. 
A total score is then calculated by summing the individual item scores, ranging from 0 
(best possible health) to 54 (worst possible health).  If any item is marked as ‘not 
applicable’ then a mean score is calculated based upon the items that were answered. 
That mean score is then multiplied by 18 to obtain a total score (Jacobs et al., 2001).  No 
cut-off scores have been reported in the literature for clinical or research for determining 
ARI disease severity; therefore, the instrument does not have norms and would not be 
considered standardized for clinical purposes (Waltz, et al., 2016). Finally, a parent 
global health assessment, a 10 cm visual analog scale (VAS), is placed underneath the 
CARIFS items with instructions to mark the perception of the child’s health on the line 
with a single mark from best to worst possible health (Jacobs et al., 2001).       
Psychometric Testing 
The first psychometric testing for the CARIFS (diary version) was performed in 
three Canadian cities, Halifax, Calgary, and Toronto, during the winter of 1998.  The 
parents of 220 otherwise healthy children, aged 0 to 12 years, with ARI symptoms in the 
previous 72 hours were enrolled in the study; 206 completed data collection. Inclusion 




past 72 hours, b) at least one upper respiratory symptom (e.g., nasal congestion, cough, 
sore throat), and c) at least one systemic symptom (e. g., fatigue, headache).  A diary 
format was designed for this study. The diary contained sixteen individual CARIFS 
instrument sheets. Each sheet was to be completed twice daily for days 1-7 and once 
daily on days 10 and 14 by the parents. No recommended time frame for completing the 
score sheets could be located in the published literature. Therefore, some parents may 
have completed each sheet at the end of each day, while others may have completed all 
16 sheets on the last day of data collection.   
At the enrollment visit, the child’s axillary temperature was recorded, and their 
parents rated the ARI disease severity by completing the first CARIFS instrument diary 
entry. The parents then completed the parent global health assessment (VAS 10 cm) part 
of the CARIFS for the child’s current state of health (Jacobs et al., 2001). Additional 
testing involved physicians and nurses completing the CARIFS as well as other 
instruments to compare ARI symptoms between instruments. 
CARIFS Reliability 
Determining reliability is a necessary process every time instruments are 
administered (Waltz, et al., 2016).  Initially, the CARIFS reliability was assessed using 
test-retest to determine its stability over time.  This was determined by comparing 
instrument scores completed by the same person at two different times on the second day 
after enrollment. The morning score was compared to the evening score with a resulting 




Internal consistency is an evaluation of reliability and is determined by 
calculating a Cronbach alpha. This can be done for a total score as well as subscale 
(dimension) scores. The Cronbach alpha is a statistical test that determines if all items in 
a group of items (be it the entire instrument or a subscale) are measuring the same 
concept. A score of 1.0 would equate to perfect internal consistency reliability, at least 
0.90 for clinical purposes, and 0.70-0.80 for research purposes (Mayo, 2015; Waltz, et 
al., 2017).  Initial testing of the CARIFS was completed in a Canadian population 
resulting in an acceptable Cronbach alpha of 0.89 for the total score only. Using similar 
psychometric testing on the CARIFS, but with parents of 178 children with ARI located 
in the United Kingdom (UK), total score internal consistency was again acceptable at 
0.85. However, somewhat lower test results were obtained for the symptom dimension 
(0.54), function dimension (0.77), and parental impact dimension (0.70).   
Validity  
Determining if the CARIFS produced valid data was accomplished through 
construct validity and responsiveness testing.  Construct validity identifies how well the 
instrument items measure what they are operationally defined to measure. A number of 
tests of validity such as convergent validity testing can be used to determine construct 
validity (Waltz, et al., 2016).  
Initial construct validity was determined for the CARIFS by using convergent 
validity testing.  As part of this testing, physicians and nurses were asked to simply score 
the severity of the child’s illness as mild, moderate or severe.  Additionally, the nurses 




Scale (YOS).  The YOS is designed to measure severity of illness in children up to three 
years old with fever in the emergency room department (McCarthy et al., 1982; Bang & 
Chaturvedi, 2009). Then the total parent CARIFS scores were compared with the a) 
parent VAS scores (r=0.52), b) YOS scores (r=0.48), c) child axillary temperatures at 
time being seen by providers (r=.29), and d) the simple assessment classifications from 
those physicians (r=0.36) and nurses (r=0.44). One explanation that has been offered for 
the weak correlation between the CARIFS scores and the axillary temperatures at 
enrollment (r=0.29), was that only 59% of the participants had a fever at enrollment. 
Shepperd et al. also approached assessing construct validity similarly except a VAS was 
used for physician and nurse assessments in addition to the parent VAS score. The 
Spearman coefficients were calculated between the CARIFS score and VAS scores from 
the general practitioner (r=0.13), nurse (r=0.35), and parent (r=0.40).         
Sensitivity, an important concept in the clinical arena when caring for and treating 
patients, is defined as the ability of an instrument to detect change over time within the 
same patient. The smaller the amount of change an instrument can pick up, the more 
sensitive the instrument (Waltz, 2016).  For the CARIFS it was hypothesized that the 
child’s severity of illness would diminish over time based on the typical course of ARI, 
thereby setting up the perfect opportunity to measure responsiveness to change.  Using an 
effect size approach, the change in total CARIFS scores were determined for 1) time of 
enrollment, 2) 8 hours post enrollment, and 3) day 3 of illness. As background, an effect 
size score above 0.5 indicates moderate change and above 0.8 indicates large change 




was 1.6, indicating that the CARIFS is very responsive to improvement over time.  Due 
to few children’s health declining over the course of the illness, the instrument could not 
be assessed for responsiveness to decline.  
Instrument Strengths and Limitations 
The primary strength of the CARIFS is that it was built upon the Kirshner and 
Guryatt process framework for assessing health indices (1985). Therefore, the 
methodological framework undertaken included item selection, scaling and reduction, as 
well as, determining the instrument’s reliability, validity and sensitivity. Additionally, 
while not a true test of validity, face validity was determined by a large number of 
parents (N=23). There are several limitations to the CARIFS that should be noted by 
clinicians and researchers prior to utilizing the instrument.  
Administration and Scoring 
The instructions for administration and scoring of the CARIFS do not appear to 
have been standardized.   An instrument should have consistent and defined 
administration guidelines, such as specifications and conditions (Waltz, Strickland, Lenz, 
2016).   In the literature, there are different versions of the administration process for the 
CARIFS, ranging from completing the instrument once a day for two weeks to just once 
during an emergency room visit.  In fact, some publications on the CARIFS provided no 
information regarding how the instrument was administered (Whitley et al., 2001; Vohra 
et al., 2007; Fischer et al., 2014).  Because the CARIFS does not have standard 
instructions for administration, users should be cautious when comparing results among 




As discussed earlier, a total score for the CARIFS is obtained by summing all 
items, and a procedure for addressing missing data has been described above.  However, 
established norms have not been located in the literature. While the CARIFS was created 
to measure disease severity of ARI, there are no identified norms for mild, moderate, or 
severe ARI disease severity.  Without the established norms to classify the severity of 
ARI, it is difficult to interpret scores for clinical or research purposes.   
Reliability Issues 
Several forms of reliability testing were performed on the CARIFS.  An 
instrument is considered reliable if it consistently measures the same attribute repeatedly 
over time.  The CARIFS had several forms of reliability testing performed, as mentioned 
above, but the testing was not performed in a controlled or consistent manner. Instrument 
stability was performed using test-retest approaches. While appropriate testing, the time 
frames between testing were vague.  Morning and evening testing (no time intervals) 
makes it is difficult to know if the instrument is indeed stable for any specified time 
interval.  Additionally, it is unknown if any activities may have occurred during the time 
intervals that may have influenced the CARIFS score, e.g., the child was given a cough 
suppressant.  In order to estimate test-retest reliability the CARIFS should have been 
administered at defined times and under standard conditions. But due to the lack of 
specificity in time intervals and conditions, users should proceed with caution and not 
assume strong instrument stability.  
Internal consistency. While an acceptable total score internal consistency has 




purposes for the three dimensions (symptoms, function, and parental impact). 
Additionally, because the alpha coefficient was so high, 0.89, it could be assumed that the 
instrument measures just one attribute (McCrae, 2011); thereby making the subscales not 
relevant to the measure.  Prior to using the three dimensions in clinical decision-making, 
the internal consistency for each one should be established at higher levels.  Further 
reliability testing should also include interrater reliability for provider groups and 
parental groups. 
Validity Issues 
While several forms of validity testing were performed on the CARIFS, questions 
of validity remain.  As a reminder, validity refers to the extent an instrument measures 
what it proposes to examine.  When validity is assessed, the instrument is not what is 
being evaluated, but rather the scores obtained from instrument. The CARIFS was 
developed using items from other instruments and the opinions of several parents and 
physicians, making validity testing extremely important.  
The stated objective of the CARIFS is to measure disease severity in children 
with ARI. However, the instrument scoring appears to be more focused on the duration of 
illness. Concern exists regarding the ambiguity of the instrument: does it indeed measure 
disease severity or duration of illness? It may be beneficial to utilize subject matter 
experts with theoretical knowledge to assist in the identification of the instrument 
construct and face validity. Additional psychometric testing might address item-content 
validity in order to determine if each item is a measure of the content domain (Waltz, et 




While issues of item-level validity exist, there may also be issues surrounding the 
instrument domains as well. Because criteria for determining the placement of the 18 
items into the domains are not provided, use of the domain scores for clinical decision-
making or research purposes should be made with caution. Factor analysis, a technique 
used to examine patterns of variance among items might be a first step in determining the 
dimensions of the CARIFS.  
As described above, CARIFS convergent validity was assessed using a modified 
version the Yale Observation Scale (YOS). However, there was no indication of how the 
YOS was adapted or if any psychometric testing had been performed on the adapted scale 
prior to its use for convergent validity testing. If this modified version did not have 
validity itself, it would not serve as an appropriate measure to determine validity for the 
CARIFS. Additionally, there were important differences in the correlation of the overall 
CARIFS scores to the different provider assessment scores as well as to the axillary 
temperatures. Further work in establishing consistency in the instrument’s validity would 
be recommended.   
Finally, a majority of the CARIFS items focus on symptoms the child is 
experiencing because of ARI.  The severity of symptoms of any disease can be 
influenced by psychological or situational factors, which the CARIFS does not measure. 
Several symptom-based theories, including University of California San Francisco 
(UCSF) Symptom Management model identify that symptoms are more than a 




environmental, sociocultural, and functional health factors may change how the CARIFS 
would measure disease severity thereby improving validity of the data it produces.  
Conclusions 
Nearly every child will experience an acute respiratory illness (Simones et al, 
2006). Therefore, a comprehensive way to measure the severity of that illness should 
exist.  Instruments that measure disease severity in children with ARI are limited. The 
creation of the CARIFS provides an opportunity to objectively measure disease severity 
for both clinical care and research but should be used with caution, especially in clinical 
decision-making.    
Instrument limitations identified in this paper are based upon questionable 
reliability and validity testing, therefore, further testing is recommended. It would be 
important to repeat reliability testing using specific time parameters for administering the 
instrument.  Furthermore, treatments during testing procedures should be documented, 
and their effects considered part of testing the reliability of the CARIFS. To improve 
validity testing, domains should be established based on factor analysis. Including the 
measurement of environmental, sociocultural, and functional health factors in any 
revisions of the instrument may provide a more complete picture of disease severity of 
childhood ARI, and potentially provide an improved instrument for measuring symptoms 
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 This chapter synthesizes the information from the three aims addressed in this 
study, and the implications for nurses, education, and future research.   
Aims 
        This dissertation concentrated on three different research questions, each 
addressed in a separate paper formatted for potential publication.  The aims were: 
1. Identify if symptom presentation over the course of influenza-like illness (ILI) 
can predict virus type in an otherwise healthy military population using 
unsupervised machine learning; Identify sub-populations with similar symptom 
experience. 
2. Describe the strain-specific clinical characteristics of coronavirus among an 
otherwise healthy US military population. 
3. Examine the psychometric properties of one of the few validated instruments 
examining disease severity of ILI: the Canadian Acute Respiratory Illness and Flu 
Scale (CARIFS). 
Research Question 1: ILI and Machine Learning 
I performed a secondary analysis of ILI symptomatology and virus type from a 
prospective study conducted by ARIC.  The first objective was to identify if unsupervised 
learning could predict virus type based on physical symptom presentation.  The second 
objective was to determine if I could identify subpopulations with similar symptom 




The symptom severity data from visits on days one, three and seven were 
analyzed with a novel approach called unsupervised learning by k-means clustering.  The 
clustering method identifies related cases with similar symptoms and clusters the cases 
together.  The symptom scores reported were analyzed individually, and not by a sum of 
scores to provide more flexibility in cluster creation.  The distribution of viral diagnosis 
was not equal.  I observed the highest number of participants in our sub sample as not 
having a virus diagnosis (289), with the second highest diagnosis being influenza A 
(107), and the lowest being bocavirus (0).  
Clustering was run with k values (number of clusters) ranging from 5 to 10.  After 
review of the initial analysis, k=7 appeared to have the most favorable results.  Chi 
square analysis showed that only one cluster had a statistically significant difference 
(p<.000) with a high coronavirus percentage (17.3%) present in the cluster when 
compared to the rest of the population.  With only one cluster showing statistically 
significant results, the approach was unable to predict virus type based on individual 
symptom presentation. 
The second objective analyzed only patient data for those diagnosed with 
influenza A, coronavirus, and rhinovirus because they had the largest number of 
patients.  Three separate analyses were run, one for each viral types.  The patients were 
clustered by symptom severity scores, as above, and then their demographic data was 
compared to against the populations to determine if any clusters represented a specific 
type of group expression.  The demographic data (attributes) included: sex, military 




following virus cohorts were clustered with k sets: influenza A (n=107) k=5, rhinovirus 
(n=101) k=5, and coronavirus (51), k=4. 
        Fischer’s exact tests were performed on the groups with identified different 
attributes.  Bonferroni post-hoc analyses were performed to identify which attributes 
within the clusters were responsible for causing the differences.  The goal was to identify 
if certain attributes caused a group to cluster together.  Analyses revealed each virus had 
at least one symptom cluster with a statistically significant difference based on patient 
attributes.  Five out of the six attributes in the rhinovirus data showed statistically 
significant differences (age, BMI, sex, smoking status, and military status).  The 
coronavirus clusters only showed the attribute of sex being statistically different amongst 
the clusters.  The clustered data for influenza A revealed statistically significant 
differences of the sex and military status attributes.     
        This research was conducted on a uniform population consisting of otherwise 
healthy military members, dependents, and retirees.  The results of this study can be used 
to help further understand the characteristics of ILIs in this unique population.  A strength 
of this research was it utilized a novel approach to analyze symptom data for ILI, and 
identified unique population attributes that may affect symptom presentation.               
Research Question 2: Coronavirus  
Strain specific differences in the four common human coronaviruses (HKU1, 
NL63, OC43, 229E) have not been well described in the literature.  Utilizing data over a 
five year period from a prospective ILI study by ARIC the similarities and differences in 




military population were described.  Demographic, geographic, and potential risk factors 
were analyzed by strain type using descriptive statistics.  The symptom severity data for 
analysis was obtained from the symptom diaries the patients filled out on a daily 
basis.  Symptom severity for days 1 through 7 were analyzed by system composite score 
and total score for each strain type.  Data was analyzed by either Fischer’s exact test (for 
categorical variables) or Kruskal-Wallis (for continuous variables) to examine clinical 
symptoms for the different corona strains. 
Descriptive analysis showed coronavirus strain 229E was more common in the 
adolescent population, while OC43 more so in adults.  Demographic attributes were not 
statistically different among the coronavirus strains.  Analysis of the system composite 
scores showed a peak in symptom severity at days 3 and 4, and tended to decrease 
thereafter.  The corona strain, HKU1, did show a statistically significant difference in 
gastrointestinal (GI) composite scores on day 4 being higher than the other strains, and 
trended higher through the course of illness when compared to the other strains.  The 
majority of participants (76%) reported lingering symptoms through day 7 of illness.  
The strengths of this study was characterizing the epidemiology of symptoms of 
the four different coronavirus strains in an otherwise healthy adolescent and adult 
military population.  Additionally, this study noted that GI symptoms occur with human 
coronaviruses, an important finding as most literature on ILI tends to overlook GI 
symptoms. With the recent outbreaks of Severe Acute Respiratory Syndrome (SARS) and 




of human coronaviruses, it is important to understand the epidemiology of all forms of 
human coronaviruses.   
Research Question 3: CARIFS Critique 
ILI is the most common diagnosis among children globally, but there are a very 
limited number of scales to capture ILI disease severity.  The Canadian Acute 
Respiratory Illness and Flu Scale (CARIFS) is one of the very few validated scales 
available for research and clinics to determine ILI disease severity in children.  A 
psychometric critique of the CARIFS was performed to evaluate its strengths and 
weaknesses.     
Upon completion of the CARIFS critique, many strengths and limitations were 
noted.  Some of its strengths include it being one of the few validated instruments to 
measure ILI disease severity and some approaches to validity and reliability testing were 
performed in the Canadian and United Kingdom populations.  The scale also had several 
limitations such as, limited content validity testing, poor administration and scoring 
instructions, and the concern that contextual information is not captured.  Some 
recommendations for the CARIFS would be to perform factor analysis to confirm the 
questions are truly measuring the outcome.  Additionally, consider the development of 
another version of CARIFS utilizing the theoretical underpinnings of the Symptom 
Management Theory.  
Implications for Nursing Practice 
        The results from this study could change how some nurses view ILI 




could change how they approach care for a patient.  Additionally, the knowledge of 
clinical manifestation of the common coronavirus will give them more confidence in 
caring for people with those common strains. 
        Most importantly, nurses should be aware of the instruments they use for patient 
care, patient evaluations, and research.  The psychometric critique of the CARIFS 
showed how an instrument that has been validated can still have numerous limitations.  It 
is important nurses understand how instruments are made and the limitations they may 
have.  If nurses are using instruments to influence change in nursing practice through 
evidence based practice research, they should perform a psychometric critique of their 
instruments.    
Nurses are now using big data sets, such as patient charts or surveys, to answer 
questions on patient outcomes.  The National Institute of Nursing Research (NINR) has 
recently added symptom science it its list of innovative questions.  They seek to fund 
studies that address current questions in symptom science such as care models and how 
outside factors influence symptom management.  The NINR has also focused on funding 
studies that can advance nursing research through data science.  There are large and 
complex datasets available that are potentially rich sources for answering important 
research questions.  The use of unsupervised machine learning is a unique approach to 
analyze complex datasets.  Recent nursing literature has started to note the benefit of 
using unsupervised machine learning to data mine the large amounts of data that is 
collected with patient care (Berger & Berger, 2004; Goodwin, VanDyne, Lin, & Talbert, 




Implications for Future Research 
This study showed how different ILI viruses can cause different symptom 
presentations in the population.  Although, the more common approach of unsupervised 
learning method was used, k-means clustering, further analysis with more sophisticated 
clustering methods should be performed.  Understanding how different clustering 
methods may be able to differentiate virus type based on symptoms presentation may 
provide important knowledge about the strengths of different clustering techniques as 
applied to symptom science.  Additionally, examining the data with principal component 
analysis or standard regression to compare findings against unsupervised learning would 
help further inform the utility of this analytic approach compared to the more traditional 
ones.  Also, comparing the analysis of the symptom score data in a variety of ways, such 
as the change in symptom score by day or the sum of scores to individual score, may 
limit the number of variables the unsupervised learning algorithm needs to consider and 
may produce different results.  With the results of the secondary analysis demonstrating 
the difference in symptom presentation by sex and age, future studies should look at 
outside factors that may influence symptom presentation. 
Future research in the field of symptoms should consider the development of 
instruments capturing symptom data by utilizing the theoretical underpinnings of the 
symptom management theory.  The theory takes all aspects (social, environmental, 
biological) of symptom presentation into account.  The critique of the CARIFS showed 




Most the viruses captured in this dataset have more than one strain that causes the 
illness.  The number of patients with complete data though limited the analysis that could 
be performed on the different strains.  The small analysis on the four common human 
strains of coronavirus showed there are differences between symptom 
presentations.  Future research should focus on understanding the clinical characteristics 
of the different strains of viruses to further our knowledge on symptom experience. 
Personal Future Research 
 As a nurse researcher I plan to continue to expand my knowledge and research in 
the field of symptomatology.  Presently, I will continue working with the ARIC dataset 
utilizing the unsupervised learning technique to expand my knowledge on this type of 
data mining and knowledge of symptom presentation. I plan to use different machine 
learning approaches to have a better understanding of which approach works better for 
the type of data I am working with.  I will further investigate how different attributes lead 
to different symptom expression in patients.  I will also pursue research comparing the 
unsupervised learning technique and traditional statistical approaches, like regression, to 
understand the similarities and differences between the approaches.     
 For my future research, I plan to use this knowledge and integrate the study of 
symptomatology with genetics.  I would like to study how a person’s genetics can 
influence symptom presentation, and determine if symptoms can be prevented or ‘turned 
off.’  Additionally, I plan to advocate the need for nurses to understand the science of 
symptomatology.  Nursing programs need to focus on the symptom management theory, 




patients as well.  Nurses are currently the main group of healthcare professionals focusing 
on the study of symptomatology, I plan to embrace that, and continue with pushing our 
profession forward in this field, so nurses are considered the experts on symptom 
management.     
Implications for Nursing Education 
Nurses spend more direct and indirect time with patients than doctors.  They track 
and follow the care of a patient closely, and are typically the first to see a change in a 
patient’s status (DeLucia, Ott, & Palmieri, 2009).  It is important for nurses to be able to 
recognize a change in symptom severity and how different attributes may affect symptom 
presentation.  A slight change in a patient’s symptom presentation can be the beginning 
of a downward spiral for them.  The quality of nursing care directly affects patient 
outcomes. 
This research demonstrates the importance for nurses to be educated in the field 
of symptomatology.  Nursing programs should have some course content focusing on the 
symptom management theory in order for nurses to understand the complex structure of 
symptom development and presentation.  Symptoms typically bring attention to an 
underlying problem.  As nurses, we have to have an understanding of these symptoms 
that may be warning signs to a potentially lethal problem.  Nurses have to look at the 
overall picture according to the symptom management theory instead of just the symptom 
itself.  
Additionally, nurses should be able to explain the importance of symptom 




conditions or the meaning behind some symptoms experienced.  Nurses need to convey 
to patients to not necessarily treat a symptom of a chronic condition, but understand why 
it is happening, so treatment of the underlying problem can be addressed and not the 
symptom.     
Conclusion 
        To summarize, symptomatology is a new field of study that is progressing 
rapidly.  Medical professionals used to treat an individual symptom instead of treating the 
entire person.  For example, if you had pain, you were prescribed an analgesic instead of 
determining an underlying problem such as depression, may be the etiology of the 
presenting pain syndrome.  Because current research has shown that symptoms are 
multiplicative, the entire patient, biological, social, environmental, needs to be examined, 
not just the area of interest.   
        The three aims of this research have a common theme about understanding the 
meaning of symptom presentation.  As discussed in symptom management theory, to 
truly understand and manage the treatment of symptoms more than just the physical 
symptom needs to be considered.  By critiquing the CARIFS, it brought my attention to 
most scales used to examine symptom severity in patients with ILI do not focus on 
outside factors.  By performing the clustering on physical symptoms only by virus type, it 
proved that unique attributes affect symptom presentation.  Additionally, the analysis of 
the four common strains of coronavirus showed each strain can have a different way of 




this study had multiple strains.  Understanding symptom presentation in different strains 
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